Differentiating innovation priorities among stakeholder in hospital care by Lambooij, Mattijs S. & Hummel, J. Marjan
Lambooij and Hummel BMC Medical Informatics and Decision Making 2013, 13:91
http://www.biomedcentral.com/1472-6947/13/91RESEARCH ARTICLE Open AccessDifferentiating innovation priorities among
stakeholder in hospital care
Mattijs S Lambooij1* and Marjan J Hummel2Abstract
Background: Decisions to adopt a particular innovation may vary between stakeholders because individual
stakeholders may disagree on the costs and benefits involved. This may translate to disagreement between
stakeholders on priorities in the implementation process, possibly explaining the slow diffusion of innovations in
health care. In this study, we explore the differences in stakeholder preferences for innovations, and quantify the
difference in stakeholder priorities regarding costs and benefits.
Methods: The decision support technique called the analytic hierarchy process was used to quantify the
preferences of stakeholders for nine information technology (IT) innovations in hospital care. The selection of the
innovations was based on a literature review and expert judgments. Decision criteria related to the costs and
benefits of the innovations were defined. These criteria were improvement in efficiency, health gains, satisfaction
with care process, and investments required. Stakeholders judged the importance of the decision criteria and
subsequently prioritized the selected IT innovations according to their expectations of how well the innovations
would perform for these decision criteria.
Results: The stakeholder groups (patients, nurses, physicians, managers, health care insurers, and policy makers) had
different preference structures for the innovations selected. For instance, self-tests were one of the innovations
most preferred by health care insurers and managers, owing to their expected positive impacts on efficiency and
health gains. However, physicians, nurses and patients strongly doubted the health gains of self-tests, and
accordingly ranked self-tests as the least-preferred innovation.
Conclusions: The various stakeholder groups had different expectations of the value of the nine IT innovations. The
differences are likely due to perceived stakeholder benefits of each innovation, and less to the costs to individual
stakeholder groups. This study provides a first exploratory quantitative insight into stakeholder positions concerning
innovation in health care, and presents a novel way to study differences in stakeholder preferences. The results may
be taken into account by decision makers involved in the implementation of innovations.
Keywords: Implementation, Information technology, Innovation, Hospital care, StakeholdersBackground
Technological innovations in health care have cured dis-
eases, reduced harm and risk in surgical procedures,
prolonged the average life expectancy and consequently
increased demand for additional care with correspond-
ing costs [1,2]. In many countries, policy makers and
management believe that innovation, and especially the
uptake of information technology (IT) innovations, will* Correspondence: mattijs.lambooij@rivm.nl
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distribution, and reproduction in any mediummake a major contribution to improved efficiency in
health care [3]. Adoption of IT-innovations is supposed
to create sustainable health care through increasing the
efficiency of care processes and increasing the retention
and attraction of employees by providing challenging
and meaningful work.
However, contrary to these beliefs and despite an
abundance of novel ideas and work practices, the imple-
mentation of innovations in hospitals is hampered [4];
10,000 new studies per year are published in MEDLINE,
but many of these potentially beneficial IT-based [5-7]
innovations fail to reach the target groups and are noted Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Lambooij and Hummel BMC Medical Informatics and Decision Making 2013, 13:91 Page 2 of 11
http://www.biomedcentral.com/1472-6947/13/91applied in daily practice. This failing may be understood
by addressing the questions of who benefits from which
innovation and who bears the costs. There are numerous
examples of innovations implemented in health care that
in hindsight failed to deliver obvious benefits [8,9], or
for which the perceptions of the benefits vary between
the actors involved [10].
An innovation is a practice or object that is perceived
as new by the actor who adopts it [11]. We assume that
an actor will adopt (start to use or implement) an
innovation when the perceived benefits of using the
innovation outweigh the perceived costs, and hence, the
new practice or object is an improvement on the current
situation. Grol et al. [4] summarized the factors that
affect the success of implementing change (including in-
novations) in health care: features of the innovation it-
self, features of the target group, features of the patients,
features of the social setting, financial features, adminis-
trative and organizational context, and features of the
methods and strategies for dissemination and implemen-
tation used [4]. Successful technological diffusion of in-
novations is seen as the result of a process of mutual
adaptation among technology producers, users, and ex-
ternal groups [11,12], and the system that adopts the
innovation. The interplay of these factors can shape the
properties of the new technology, the use of the technol-
ogy, the organizational context, and the societal context.
Studies identify physicians as a barrier to be overcome
in the implementation of, especially administrative, IT
innovations [13]. However, not all delay can be blamed
on physicians since some of the IT software has note-
worthy flaws, adding unnecessary costs to the adoption
of innovation for the users [14]. This may explain part of
the users’ resistance or avoidance strategies [15,16]. These
resistance or avoidance strategies may be inspired by polit-
ical considerations and power struggles, which may affect
the diffusion of innovations as much as more ’rational’
considerations such as benefits of the innovation [17].
In this paper, we focus on one aspect of the social set-
ting of adoption of innovations: stakeholders’ preferences
regarding IT innovations and their expected benefits.
Monetary costs may be an important cause for slow diffu-
sion [18]. In this study, however, the costs and benefits are
broader than monetary. The costs to and benefits for the
different actors will be at different levels of the innovation
process: the environmental level (e.g., a benefit may be im-
proved exchange of information; a cost may be renewing
work flow with external partners); the organizational level
(e.g., a benefit may be solving an organizational problem;
a cost may be investment in new infrastructure, resistance
in the organization, providing employees with new skills
(training, education)); the social level (social support or
negative attitudes of co-workers); the psychological level
(feelings of improved self-efficacy or loss of control); andthe user level (better quality of work, versus initially being
less productive because a new way to work has to be
learned) [19,20].
Stakeholders are known to disagree on the relative im-
portance of innovations and may therefore use their re-
sources to influence other stakeholders [21] and resort
to politics and power to affect implementation processes.
Politics and the power balance between stakeholders
may be particularly important for innovations that span
a large part of an (health care) organization where mul-
tiple stakeholders holding different positions in the
organization are mutually dependent in the implementa-
tion and utilization of the innovation. The different posi-
tions of stakeholders and the concomitant differences in
priorities and agendas are likely to affect each stage of
the implementation process. In all stages, from the first
stage of experiencing and defining a problem, to looking
for solutions, to balancing investments against the im-
provements and the evaluation, the differences in struc-
tural (stakeholder) positions will affect the costs and
benefits for the different stakeholders and the conse-
quent preferences and priorities of the stakeholders.
The understanding of differences in positions between
stakeholders thwarting the implementation of innovations
is not new but has received little attention in empirical
research so far, as far as we know [11,22-24]. It has been
argued that when the implementation of clinical informa-
tion systems is purely seen as a technical implementation
rather than a complex social implementation, the chances
of failure are larger [16,25]. In some models, the presence
of stakeholders is mentioned [17], and studies have shown
that when stakeholders disagree on the priority of the
innovation, uptake will be difficult [26]. Applying stake-
holder theory [27] to the implementation of innovations
in health care, organizations may better understand why
the diffusion of possibly valuable innovations proceeds
more slowly than many stakeholders wish it would. Be-
cause of this slower diffusion, the potential benefits of IT
innovations may be hampered unnecessarily.
The preference structures of the stakeholders are likely
to be based on their perceived costs and benefits of the
innovation. For instance, doctors misspelling diagnoses
[15] did not do so because they wanted to be rebels, but
because their perceived costs of the time lost by clicking
on pop-ups were higher than the added safety value of
the warning of dangerous combinations of medicines.
We expect to find similar cost–benefit estimations for
other innovations and for other stakeholders, explaining
their respective preference structures. In turn, we expect
that when the differences between these preference
structures become larger, the speed of diffusion of inno-
vations will slow down.
The questions addressed by this paper are therefore: Do
different stakeholders have different preference structures
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health care? Can these differences be explained by differ-
ences in the costs and benefits associated with the innova-
tions for the stakeholders?
Methods
Identifying the stakeholders
Using the three decision systems put forward by Greer
[28], we will first identify three groups of stakeholders
involved in the implementation of innovations in hospitals:
physicians and nurses (from the medical-individualistic de-
cision system), hospital management (from the fiscal man-
agerial decision system) and the hospital boards (from the
strategic-institutional decision system). We will separate
the nurses from the physicians because they hold different
organizational positions within hospitals, which may affect
their preference structures.
Subsequently, we take the stakeholder perspective one
step further than Greer does by following Freeman, who
states that stakeholders are those groups and individuals
who can affect or are affected by the achievement of the
organization [27]. The main stakeholder group, affected
by innovations and therefore included in the study, is
the patients. Two relevant stakeholders we included in
the analysis, and are labeled ‘external determinants’ of
the innovation decisions by Greer, are the government
and the insurer. We will also include these groups in the
analysis. One goal of government is to make the health
care system future-proof by facilitating the diffusion of
efficiency-enhancing innovations. Insurers will have to
pay for many of the innovations that are introduced and
will therefore also influence the process by their deci-
sions to reimburse innovations or not.
Selection of innovations
Literature search
In a two-stage selection process, we identified IT innova-
tions in health care that may realistically be expected to be
beneficial to hospital care in the (near) future. The first
step was a literature scan of published research articles
in Scopus and Web of Science. The queries were focused
on innovations or new technologies in hospital care
(Additional file 1 for search queries). This yielded 450 hits
(Scopus 280, and Web of Science 119). The two authors
identified the relevant articles and reached consensus on
which papers to include, resulting in 140 included articles.
Subsequently, the article abstracts were studied for rele-
vant IT innovations. Fifty-one IT-innovations related to
hospital care were identified. These innovations were clus-
tered according to two dimensions: distance to the health
care process (i.e., the distance depends on the frequency
of interactions with patients or healthcare providers, with
a high frequency implying a short distance and a low fre-
quency implying a long distance) and size of investments(including all costs such as money, time delay, reorga-
nization of care processes, and training, from the perspec-
tive of the stakeholder that needs to make the investment)
(see Table 1).
These two dimensions are likely to affect the costs and
benefits of different innovations for the actors involved.
The size of the investment is directly tied to costs (both
monetary and non-monetary aspects such as organiza-
tional change), and distance to health care may explain
differences in impact on work practices for different ac-
tors. For example, in the upper right cell of Table 1, the
“Full-text search engine for using narrative data in elec-
tronic health records” is likely to be beneficial to people
analyzing patient data, such as analysts and decision
makers, but it is unlikely that many clinicians are af-
fected by this innovation. In the same column in the
bottom row, we find “Computerized clinical decision
support by app on a PDA” (a PDA is a personal digital
assistant). It is likely that this innovation will affect the
work practice of clinicians because of the direct avail-
ability of information to support decisions they need to
make several times per day, while this innovation is not
likely to majorly affect the work practice of board mem-
bers (provided they are not active clinicians as well).
Using these two dimensions, the innovations were divided
into nine clusters (Table 1).
We asked 10 experts (see the next section for further
explanation) whether they knew of potentially beneficial
innovations that were not included in the table. This
resulted in an additional 11 innovations, resulting in 62
innovations in the matrix. Table 1 presents the final list
of innovations and how many times these innovations
were selected by the experts.
Expert judgments in interviews
With the ensuing matrix, we approached 10 experts ask-
ing them to identify one innovation per cluster (each cell
in Table 1 presented a cluster) from which the experts
expected it would yield considerable progress in terms
of quality of care and cost-efficient care. We allowed the
experts to pick two or three innovations if they were un-
able to identify the innovation that was most beneficial
in the specific cluster. Each time that an expert selected
an innovation, the innovation was marked with a score
1. From the sum scores of their choices and their com-
plementary justification, we selected nine innovations
for the analytic hierarchy process (AHP) in the next
phase.
The group of experts consisted of two active hospital
physicians, one physician working outside of the hos-
pital, one member of hospital staff, two directors of
advice organizations specialized in hospital IT and man-
agement, and four researchers with expertise of IT in
health care (e.g., E-health). In Table 1, the number of
Table 1 Results of a literature search, by investment and distance to a care process, for expert opinion on relevance
(quality, efficiency and sustainability of hospital care)
Size of investments
Large investments in time, money
and human capital strategic
Medium investments Small investments in time, money
and human capital, strategic
Large distance to patient care
(concerning hospital and its
surroundings financial functions,
analytics (not patient level))
• Beacon community program to
improve nation’s health care
• (2) Infection control
knowledge management
• (1) Full-text search engine for using
narrative data in electronic health
records
• (2) Antiviral information
management system
• (2) National-level connectivity
Electronic Patient File (EPF)
• Biased sample hospital-based
area disease estimation
• Electronic systems to collect
client-level vaccination data
• Performance improvement systems
• (3) Performance management
systems
• Visual diagrammatic language
techniques to analyze work
processes
• Electronic logistics information
systems
• (2) Programming model to support
operating room planning
• Administrative IT
Medium distance to patient care
(concerning the professional and the
hospital organization)
• (3) Interorganisational Electronic
Health Record (Regional)
• eReferrals to specialists • (1) Electronic prescriptions
• Internet and electronic data
mining in pathology
• PDAs
• Picture archiving and
communication system
• Communication systems in
radiology
• (1) Blackberry as a clinical
communication tool
• Emergency medicine information
systems
• Electronic medical record
system of outpatient workflow
• Voice recognition dictation
• (1) Clinical information systems
(e.g., in radiology)
• Identification device
technology to analyze work
processes
• (2) Web-based distance learning
• (2) Patient data management
system
• Computerized display of
laboratory and radiology
results
• Computerized ordering systems
• (2) Electronic patient records
(third generation; registration and
structured documentation, clinical
support), within one institution
• Systems to analyze patient
waiting and progress
• (3) Tablet as a clinical information
tool
• Ambulatory referral
management system
(management of patient
routes)
• (2) Computerized clinical decision
support by desktop/laptop
• (1) Inter-colleague consultation
• Indoor positioning
• Remote-controlled
transfusion management
• Automated medication-use
process for prescribing and
dispensing medication
(including computerized
prescriber order entry)
• Electronic discharge systems
• (3) Bar code medication
administration technology
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Table 1 Results of a literature search, by investment and distance to a care process, for expert opinion on relevance
(quality, efficiency and sustainability of hospital care) (Continued)
• Computerized physician
order entry for prescribing
medication and recording
medication administration
• (2) Electronic health records
within hospital
Small distance to patient care
(concerning interaction between the
patient and care professional)
• (1) Planning software surgery • (1) Remote patient
management
• (4) Virtual consultations
• (2) Computer-assisted surgery,
using a robot
• (3) Telenursing
(application of Telecare)
• (2)Voice link between elderly and
caregivers (part of assisted living
facility)
• (1) Three-dimensional
ultrasonography
• (4) Telepathology
(application of Telecare)
• (3) Teleradiology
(application of Telecare)
• (2) Patient safety alert system
• (1) Smart Health Communities • (1) Computerized clinical decision
support by app on a PDA
• (5) Self-testing and online
automated management
• (2) E-triage
• (1) Telemonitoring of heart
failure (application of Telecare)
• Virtual microscopy system
• (1) Digital imaging
• (5) Portal by hospital for
appointments and reminders
• (4) Portal by hospital for online
consulting (mail, tweet, chat)
• (4) Portal by hospital for
peer-group-contact patients
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given in parentheses.
From the expert scores, the following IT-based innova-
tions were selected to be included in the AHP: regional
EPF (Electronic Patient File), computer-assisted telesur-
gery using a robot, barcode medication administration
technology, telepathology, self-testing and online auto-
mated management, a digital hospital portal, planning
software to support operating room planning, a PDA with
decision support, and virtual consultations (see Additional
file 2 for a short explanation of and additional literature
on these innovations).
Analytic hierarchy process
We employed the AHP method as an analytical tool
with which to prioritize decision alternatives using mul-
tiple criteria to quantify the differences in stakeholder
positions on the selected IT innovations [29-32]. The
first step of the AHP is to compose a hierarchical struc-
ture, including the objective, the main and sub-decision
criteria and the alternatives. In the second step, the AHP
offers a pairwise comparison approach to calculate the
relative weights for each of the decision criteria and the
preference priorities for the alternative innovations.To calculate the weights, the respondents judged each
pair of decision criteria on a scale from 9 to 1 to 9, with
the two extremes (score 9) indicating that the present
criterion is extremely more important than the one it is
compared to, and the middle of the scale (1) indicating
equal importance. In a similar manner, the preferences
for the innovations can be judged in comparison with
current care. For these pairwise comparisons, a score of 9
indicates an extreme preference for either the innovation
or current care.
An average of the individual judgments in the pairwise
comparisons can be calculated to represent the judg-
ment of a group as a whole. The AHP provides a meas-
ure of consistency, showing whether each pairwise
comparison is logically sound with regard to the remain-
der of the comparisons. When inconsistency is accept-
able, weighting factors and performance priorities are
calculated employing the principal right eigenvector
[33]. As such, the weighting factors assigned to the out-
come measures represent the relative importance of each
of these outcome measures, while the priorities repre-
sent the relative preferences for the innovations. The
overall priority of an innovation per stakeholder group is
the weighted sum of the relative preferences for the
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to weight these relative preferences, they are multiplied
by the importance of the corresponding decision criter-
ion. See Saaty [33] for a more in-depth explanation of
AHP mathematical approaches.
Criteria
The criteria along which the innovations are judged are
related to the costs and benefits on the various levels on
which the stakeholders operate. The decision criteria se-
lected are a) improvement in efficiency in health care
(through 1) improvement of work processes and 2) in-
creased self-management of patients), b) health gains of
the patient after implementation of the innovation, c)
satisfaction with the care process (through 1) employee
satisfaction and 2) patient satisfaction), and d) required
investments to implement the innovation (see Figure 1).
Respondents
We met the threshold of five members for all stake-
holder groups, by adding one board member to the
managers in the sample. We approached possible re-
spondents through networks of the researchers and the
networks of colleagues, and tried to ‘snowball’ the con-
tacts of our respondents. The patients and nurses were
gathered from a survey panel of an external research
agency. Both were random samples. The nurses were in-
cluded if they were working in a hospital and were in-
volved in patient care at the moment of filling out the
questionnaire. Patients were included who had been hos-
pitalized for at least one night in the two years prior to
filling out the questionnaire. Physicians were contacted
through personal networks of coworkers of the authors.
We included physicians that were actively working in aRestructu
care proc
Initial fin
investme
Patient s
****
Satisfacti
professio
Satisfaction with the 
care processes
Required investments
in health care
Efficienc
care orga
Self man
patient *
Efficiency of health care
Health gain (safety and efficacy)
Compare the 
need of 
adoption of IT 
innovations
Figure 1 Hierarchical structure with decision criteria.hospital. We succeeded in including physicians of vari-
ous age groups. Managers were recruited through the
networks of co-workers; we contacted three insurer
companies, and at one of the companies, a number of
employees working in the department involved with
innovation in health care agreed to cooperate. The
policymakers were recruited at the Ministry of Health,
Welfare and Sport by one of the authors who spent one
day a week doing several research activities. Eventually,
62 respondents were included in our sample. All respon-
dents worked in the Netherlands at the time of filling
out the questionnaire. Table 2 presents the numbers per
stakeholder group in parentheses.
Data collection
Preferences for the IT innovations were elicited through
an online survey. The online questionnaire included an
AHP example to illustrate how the respondents were to
score their preferences for the IT innovations, and the
relative importance of the decision criteria. Subsequently,
the decision criteria and IT innovations were described.
As a first step of the preference elicitation, the respon-
dents were asked to pairwise compare the importance of
the criteria. To compare all criteria, the respondents
judged seven pairwise comparisons on the validated AHP
scale, ranging from equally important to extremely im-
portant. As a second step, the respondents compared, for
each of the decision criteria, their preferences for the IT
innovations in comparison with current care. The respon-
dents judged 63 pairwise comparisons, to prioritize the
nine IT innovations according to the seven decision cri-
teria. This time the AHP scale ranged from equally pre-
ferred to extremely preferred. On the basis of these
judgments, the overall priorities for the IT innovations
were calculated with the AHP.rering of 
esses ******
ancial
nt *****
atisfaction
on care 
nals ***
y of health
nization **
agement by
** e.g. labor  productivity 
care professionals, costs 
internal processes
* more care activities 
performed by the patient
**** e.g. new staff, purchase
equipment, training
****** e.g. changing roll/functions, 
responsibilities, planning, budget 
allocation
*** e.g. autonomy, 
challenges en meaningful
tasks and cooperation
**** e.g. satisfaction contact 
care professionals and 
realization of the care process 
Table 2 Weighting factors of the decision criteria
Decision criterion Patients (15) Nurses (22) Physicians (9) Managers (9) Health insurers (5) Policy makers (6)
Efficiency 0.22 0.21 0.20 0.29 0.29 0.46
Patient self-management 0.45 0.35 0.28 0.24 0.45 0.64
Efficiency of organization 0.55 0.65 0.72 0.76 0.55 0.36
Health gain 0.42 0.35 0.36 0.28 0.43 0.28
Satisfaction 0.28 0.31 0.33 0.33 0.18 0.15
Health care professionals 0.21 0.52 0.42 0.26 0.21 0.26
Patients 0.79 0.48 0.58 0.75 0.79 0.74
Investments 0.09 0.14 0.11 0.11 0.10 0.11
Initial 0.25 0.45 0.32 0.43 0.25 0.24
Restructuring 0.76 0.55 0.68 0.57 0.76 0.76
(Values in boldface add up to one; values in regular face are sub-criteria and also add up to one. The larger the value, the more important the decision criterion.)
Numbers in parentheses are the number of stakeholders in each group.
Lambooij and Hummel BMC Medical Informatics and Decision Making 2013, 13:91 Page 7 of 11
http://www.biomedcentral.com/1472-6947/13/91Results
Importance of the decision criteria
Table 2 shows the importance of the decision criteria to
the stakeholder groups. The priorities of all main deci-
sion criteria (efficiency, health gain, satisfaction and in-
vestment) and all sub-criteria related to the same main
criterion sum up to one. The scores are to be interpreted
as relative weights of importance; the higher the score,
the higher the relevance of the criterion according to the
stakeholder group.
Within the stakeholder groups, the consistency ra-
tios are 0.02 for patients, 0.04 for nurses, 0.13 for phy-
sicians, 0.10 for managers, 0.03 for health insurers,
and 0.02 for policy makers. All consistency ratios are
acceptable.
Efficiency is emphasized most strongly by policy makers
(0.46; being the highest value), while patients, nurses and
physicians least emphasize the importance of efficiency
(0.22, 0.21 and 0.20 respectively). Health gain is judged to
be most important by health insurers, nurses and patientsTable 3 Prioritization of innovations
Innovation Patients Nurses Physicia
Baseline innovation 0.05 0.05 0.05
Virtual consultation 0.08 0.09 0.08
Digital hospital portal 0.10 0.12 0.11
Planning operations 0.12 0.13 0.11
Telepathology 0.08 0.07 0.09
Barcodes 0.16 0.13 0.09
PDA 0.09 0.10 0.16
Telesurgery 0.08 0.06 0.07
Regional EPF 0.15 0.15 0.19
Self-tests 0.09 0.10 0.06
Values in columns add up to one. The larger the value, the more important the inn(0.43, 0.35 and 0.42 respectively). Satisfaction is relatively
important according to physicians, managers and nurses
(0.33, 0.33 and 0.31 respectively). For managers and physi-
cians, satisfaction (particularly patient satisfaction) can be
even the most important decision criterion in selecting IT
innovations.Preferences for the IT innovations
Table 3 shows the preferences of the different stake-
holder groups for the IT innovations. A higher priority
reflects a higher preference for this innovation. The pri-
orities of all innovations add up to one. Results provid-
ing further insight into the distribution of priorities of
individual respondents within each stakeholder group
are presented as box plots in Additional file 3.
Patients appear to prefer medication barcodes and the
regional electronic patient file (EPF), although their
opinions on the value of the two innovations vary. Argu-
ments are most strongly related to the perceived healthns Managers Health insurers Policy makers
0.05 0.04 0.05
0.09 0.11 0.09
0.12 0.12 0.11
0.11 0.09 0.11
0.08 0.10 0.07
0.12 0.10 0.13
0.09 0.11 0.09
0.06 0.09 0.06
0.14 0.11 0.11
0.13 0.13 0.18
ovation to the stakeholder group.
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innovations.
Nurses also prefer most strongly the regional EPF and
barcodes, together with planning software for opera-
tions. Similar to the patients, the nurses strongly differ
in judgment about the expected value of barcodes and
the EPF (see Additional file 3: Figure A2). The regional
EPF is particularly valued because of its expected health
gains and impact on satisfaction, the planning software
because of the high satisfaction expected, and the
barcodes because of the perceived health gains.
Physicians prefer the EPF most followed by the PDA
because of their effects on satisfaction, health gains and
efficiency. They particularly agree on the value of the
PDA but less so on the value of the EPF.
Managers strongly prefer the regional EPF on account
of its expected health gain and satisfaction, self-tests on
account of the expected health gain, satisfaction and effi-
ciency gain, and the digital hospital portal on account of
the expected efficiency, satisfaction and health gain. No
strong disagreements are found in the preference for the
EPF, yet the value of self-tests is disputed among the
managers.
Health care insurers prefer self-testing because of the
expected efficiency and health gain, the digital hospital
portal because of the low investment and efficiency gain,
and the PDA because of its expected effect on satisfac-
tion and health gain. Policy makers prefer self-testing
on account of its expected increase in efficiency, barcodes
on account of their health gains, and the digital hospital
portal on account of the expected satisfaction to patients.
Policy makers strongly prefer self-tests, because of
their strong, favorable effect on efficiency as expected by
them. Self-tests are significantly favored over multiple
other innovations (95% CI). This preference is followed
by the preference for barcodes due to the expected
health gain, and the digital hospital portal due to its
expected effect on patient satisfaction.
Among the innovations, the regional EPF is in the top
three preferences of four out of six stakeholders (pa-
tients, nurses, physicians and managers). However, the
stakeholder most likely to bear a substantial part of the
cost, the policy makers, did not appear to have much
faith in this innovation at the time they filled out the
questionnaire.
Even though preferences for barcodes strongly vary
within most stakeholder groups, barcodes are among the
top three preferences of four stakeholders (patients,
nurses, physicians and policy makers). An important
benefit of barcodes is perceived to be improved medica-
tion safety. Proper use will reduce incidents, and their
resulting turmoil, (physical) damage and additional need
for care. Policy makers, in particular, appear to be more
unanimously convinced of this potential benefit.A particularly large difference is found for digital hos-
pital portals and self-tests. Managers, insurers and policy
makers highly value these innovations, emphasizing their
benefits, while the other stakeholder groups score these
innovations lowly. The two innovations are clearly aimed
at improving self-management and health care efficiency.
These goals are important to the stakeholders who have
to pay for the innovations (policy makers and insurers)
and seem less important to the stakeholders who need
to change their work practices because of increased self-
management. Policy makers assigned a significantly
higher priority to self-tests than patients did (95% CI).
Conclusions and discussion
The main questions of this paper were: Do different
stakeholders have different preference structures con-
cerning the relative relevance of IT-innovations in health
care? And, can these differences be understood from the
differences in the costs and benefits associated with the
innovations for the stakeholders? Understanding the dif-
ferences in preferences and subsequent priorities in
innovation agendas of different stakeholders may lead to
an understanding of the differences in the speed of diffu-
sion of innovations.
We found differences in preferences between six
stakeholder groups with regard to nine IT innovations in
hospitals. For example, substantial differences were
found in the preference for self-testing. Patients who
would play a vital role in the effective implementation of
self-tests do not give self-tests a high priority. This can
be partly understood by cost–benefit considerations. To
conduct self-tests, patients have to learn new skills and
take responsibility for their care process, which they may
not aspire to do so. The benefits of more efficient health
care are mainly found within the system.
The highest level of consensus between the six stake-
holder groups was found for a regional EPF. Even the
stakeholders who may have to bear substantial costs in
terms of having to change their daily routines (i.e., nurses
and physicians) see the added benefits of the innovation.
The implementation of an EPF involves different costs for
different stakeholders. Nurses and physicians need to
change their work practices in the sense that many of their
treatment-related activities are computerized. (This change
depends on the interface, but working with stations, the
change can be quite cumbersome.) Hospitals need to in-
vest in IT systems and national policy makers need to in-
vest in regional data infrastructures. The perceived
benefits of EPF are, however, not without controversy.
Among the stakeholder groups, judgments differed most
strongly on the EPF as well as medicine barcodes and
self-tests.
The strongest preferences found in this study are those
of the policy makers for self-tests, and those of the
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could result in a decrease in costs because part of the
disease diagnosing process is done by the patients them-
selves, thereby reducing the number of general-practitioner
consultations. Therefore, they expect a gain in efficiency
of care. The physicians prefer the PDA, probably because
of the ease of use, with all relevant data being readily avail-
able at the patient’s bedside or the operating table. For the
PDA to work, a well-functioning EPF is necessary, which
is their second preference. This seems to indicate that the
physicians in our study will embrace the benefits of a
well-functioning EPF with a mobile interface.
There were indications that stakeholder preferences
can be understood from the benefits they gain from the
innovation. We also saw that these benefits differ between
stakeholders, affecting their prioritization of which inno-
vation to implement first. We saw little direct evidence
of costs having a major effect on the decisions of the
stakeholders.
In terms of the relative importance of the decision cri-
teria, policy makers deviate from the other stakeholders.
To policy makers, efficiency in health care is the most
important factor in deciding whether an innovation has
added benefits. For patients, nurses and insurers, health
gains constitute the decisive factor in deciding on bene-
ficial innovations, and for physicians and managers, the
decisive factor is (patient) satisfaction.
All policy makers operated on the national level and
were very concerned about the increasing health care ex-
penditure. This concern was translated in the high prior-
ity of the efficiency gains due to the innovations. In the
interviews, policy makers indicated that they use dif-
ferent tools to steer the innovation process. Besides
implementing taxes, making inspections and providing
funding, they may establish contact between innovators
and care providers to start meaningful cooperation. The
interviews revealed an important difference between pol-
icy makers and other stakeholders, in that the majority
of them found it difficult, if not impossible, to appreciate
the implications of single innovations. They were better
equipped to discuss general directions and macro conse-
quences of innovations.
None of the stakeholders indicated that they consider
investment to be the most relevant factor in deciding on
the added value of an innovation. It should be noted that
these outcomes are based on subjective expectations,
and not on evidence from health economic studies. A
drawback of this study is that the respondents reported
their subjective expectations and these expectations may
differ from real life choices that stakeholder groups
make. The relatively small weight that was assigned to
the costs may point towards such bias.
We measured the preferences of the various stake-
holders. These preferences are likely to affect thedecisions on adopting innovations. The preferences ap-
peared to be related to the cost–benefit ratio of each
stakeholder. This cost–benefit ratio is affected by the
stakeholders’ position in an organization or a health care
system. We did not study the actual effect of preferences
on decision making. The effect of preferences on deci-
sions about adoption may be the topic of another study.
Even though we tried to be specific in our descriptions
of innovations, we also had to find a description that
would be understood by all stakeholders. The result may
have been too general a description of the innovations.
For instance, the EPF has many different applications
and methods of operation. It may have been that differ-
ent respondents had different ideas of the EPF while an-
swering the question, based on their own experience.
Another way to improve this study is to increase the
number of respondents. It was found particularly diffi-
cult to have physicians answer the questionnaire. We re-
ceived feedback that some of them found it too difficult
to answer the questions, or that completing the ques-
tionnaire was too time consuming. Still, we explored the
possibilities for the use of AHP in innovation research,
and even with the relatively small number of respondents,
believe that we have obtained promising results that can
be understood in terms of the stakeholder framework. Later
studies may build on the ideas presented in this paper.
If in subsequent studies it is possible to increase the
number of respondents, further differentiations among a
larger number of stakeholders may be possible. For in-
stance, we did not further differentiate the management
of hospitals. However, when managers operate on differ-
ent levels or in different positions in an organization,
this may affect their preferences. The differences are
expected to be smaller than those between the stake-
holder groups we included, but these small differences
may delay the innovation processes. With further differ-
entiation, an even more diverse picture of differences be-
tween stakeholders is likely to emerge. An increased
number of respondents may also be used to correct ana-
lyses for aspects such as cultural differences and resem-
ble the wider variety of health care organizations.
What would we expect concerning the speed of the
diffusion of the innovations that were included in this
study? Virtual consultations, telepathology and telesur-
gery did not appear in any of the top three preferences
of any of the stakeholders. We therefore do not expect
rapid and broad diffusion of these innovations soon. The
planning of operations is ranked by patients and nurses
to be important; however, it will need to be implemented
by the hospital organization. We believe that the plan-
ning is an inevitable step in creating an efficient hospital
and expect it to diffuse at a medium rate. Self-tests are
highly ranked by the stakeholders that do not use it
(managers, health insurers and policy makers), but not
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slow implementation of self-tests. For the digital hospital
portal, we find a similar preference structure. However,
these kinds of implementations are performed more by
the hospital organization. This type of innovation may
therefore diffuse more quickly. Barcodes are seen as use-
ful innovations by most of the stakeholders. The use of
barcodes may therefore diffuse quickly with the support
of all stakeholders. The use of a PDA is mainly found to
be important by the physicians and the EPF by most of
the stakeholders close to the care process. Even though
the two are seen in this study as separate innovations,
the PDA can be used as a mobile interface for the EPF.
If these two technologies are combined, a mobile source
of information becomes available to the care profes-
sionals, possibly integrating data input more closely to
the care process. The combination of readily available
information with quick and easy data input may create
more momentum for the ongoing diffusion of registra-
tion of patient data. Future research may empirically test
these expectations.
Conclusion
For innovation research, this means that when studying
implementation, taking account of the number of stake-
holders involved in the implementation decision and
how they benefit from or pay for the implementation
and use of the innovation may increase the understand-
ing of the (lack of ) speed of the diffusion process. If one
of the stakeholders in any part of the process faces costs
that exceed the benefits, the process may be stopped in
the implementation phase where involvement of the par-
ticular stakeholder is crucial. Knowing more about costs
and benefits at a stakeholder level may therefore better
explain why diffusion of particular innovations is delayed
than taking into account possible costs and benefits on a
more aggregate level.
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